Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated.

Literature DB >> 27880978

Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated.

Lindsey Kennedy^1,2, Heather Francis^1,3,2.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2017 PMID： 27880978 PMCID： PMC5319919 DOI： 10.1002/hep.28959

Source DB: PubMed Journal: Hepatology ISSN： 0270-9139 Impact factor: 17.425

× No keyword cloud information.

10 in total

1. HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors: C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal: Nature Date: 1991-05-23 Impact factor: 49.962

2. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors: T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal: J Virol Date: 1990-12 Impact factor: 5.103

Review 3. Mechanisms of HBV-induced hepatocellular carcinoma.

Authors: Massimo Levrero; Jessica Zucman-Rossi
Journal: J Hepatol Date: 2016-04 Impact factor: 25.083

Review 4. Tissue-specific function of farnesoid X receptor in liver and intestine.

Authors: Yan Zhu; Fei Li; Grace L Guo
Journal: Pharmacol Res Date: 2011-01-04 Impact factor: 7.658

5. Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity.

Authors: Yuan-Hua Chen; Xiao-Guang Hu; Yan Zhou; Zhen Yu; Lin Fu; Gui-Bin Zhang; Qing-Li Bo; Hua Wang; Cheng Zhang; De-Xiang Xu
Journal: J Immunol Date: 2016-11-07 Impact factor: 5.422

6. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.

Authors: Guodong Li; Bo Kong; Yan Zhu; Le Zhan; Jessica A Williams; Ossama Tawfik; Karen M Kassel; James P Luyendyk; Li Wang; Grace L Guo
Journal: Toxicol Appl Pharmacol Date: 2013-06-26 Impact factor: 4.219

Review 7. Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors: Debajit Dey; Manidipa Banerjee
Journal: J Clin Transl Hepatol Date: 2016-09-25

8. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.

Authors: Weihua Li; Man Li; Dongjiang Liao; Xinpeng Lu; Xia Gu; Qianqian Zhang; Zhixiang Zhang; Hui Li
Journal: Oncotarget Date: 2016-08-23

9. Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.

Authors: Mingyue Zhu; Yan Lu; Wei Li; Junli Guo; Xu Dong; Bo Lin; Yi Chen; Xieju Xie; Mengsen Li
Journal: J Cancer Date: 2016-05-12 Impact factor: 4.207

10. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.

Authors: Kai-Yu Ng; Stella Chai; Man Tong; Xin-Yuan Guan; Chi-Ho Lin; Yick-Pang Ching; Dan Xie; Alfred Sze-Lok Cheng; Stephanie Ma
Journal: Oncotarget Date: 2016-04-26